Effect of Rps6 hemizygosity and Trp53 on blood counts and eADA activity*
. | Nonmutant† . | Rps6lox/+; Tg.MxCre/+ . | Rps6lox/+; Tg.MxCre/+; Trp53ko/+ . | Rps6lox/+; Tg.MxCre/+; Trp53ko/ko . |
---|---|---|---|---|
No. of animals | 17 | 20 | 12 | 8 |
WBC, × 103/μL | 7.58 ± 0.47 | 4.47 ± 0.35a‡ | 4.12 ± 0.53 | 6.39 ± 0.75b‖, NS¶ |
RBC, × 106/μL | 9.72 ± 0.13 | 5.85 ± 0.19a‡ | 7.03 ± 0.11a§ | 9.12 ± 0.83a‖, NS¶ |
MCV, fL | 47.0 ± 0.4 | 59.8 ± 0.7a‡ | 55.7 ± 0.7a§ | 48.3 ± 2.2a‖, NS¶ |
Platelet count, × 103/μL | 930 ± 17 | 1490 ± 89a‡ | 1181 ± 65b§ | 911 ± 89b‖, NS¶ |
No. of animals | 6 | 6 | 4 | 5 |
eADA, IU/g hemoglobin | 1.06 ± 0.11 | 2.54 ± 0.45c‡ | 2.09 ± 0.15 | 1.13 ± 0.19c‖, NS¶ |
. | Nonmutant† . | Rps6lox/+; Tg.MxCre/+ . | Rps6lox/+; Tg.MxCre/+; Trp53ko/+ . | Rps6lox/+; Tg.MxCre/+; Trp53ko/ko . |
---|---|---|---|---|
No. of animals | 17 | 20 | 12 | 8 |
WBC, × 103/μL | 7.58 ± 0.47 | 4.47 ± 0.35a‡ | 4.12 ± 0.53 | 6.39 ± 0.75b‖, NS¶ |
RBC, × 106/μL | 9.72 ± 0.13 | 5.85 ± 0.19a‡ | 7.03 ± 0.11a§ | 9.12 ± 0.83a‖, NS¶ |
MCV, fL | 47.0 ± 0.4 | 59.8 ± 0.7a‡ | 55.7 ± 0.7a§ | 48.3 ± 2.2a‖, NS¶ |
Platelet count, × 103/μL | 930 ± 17 | 1490 ± 89a‡ | 1181 ± 65b§ | 911 ± 89b‖, NS¶ |
No. of animals | 6 | 6 | 4 | 5 |
eADA, IU/g hemoglobin | 1.06 ± 0.11 | 2.54 ± 0.45c‡ | 2.09 ± 0.15 | 1.13 ± 0.19c‖, NS¶ |
eADA indicates erythrocyte adenosine deaminase activity; MCV, mean corpuscular volume; NS, not significant; polyI:C, polyinosinic:polycytidylic acid; RBC, red blood cell count; and WBC, white blood cell count.
Blood counts were evaluated 16 weeks after treatment with polyI:C compound. Blood counts given as mean ± SEM with P values based on multiple regression where sex and genotype are factors. A subset of animals was evaluated for eADA activity and values are mean ± SEM with P values based on a 2-tailed Student t test, aP < .001, bP < .01, cP < .05.
+/+ or Rps6lox/+.
Nonmutant vs Rps6lox/+;Tg.MxCre/+.
Rps6lox/+;Tg.MxCre/+ vs Rps6lox/+;Tg.MxCre/+;Trp53ko/+.
Rps6lox/+;Tg.MxCre/+ vs Rps6lox/+;Tg.MxCre/+;Trp53ko/ko.
Nonmutant vs Rps6lox/+; Tg.MxCre/+;Trp53ko/ko.